Cargando…

Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes

Detalles Bibliográficos
Autores principales: Ardestani, Amin, Tremblay, Matthew S., Shen, Weijun, Maedler, Kathrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895035/
https://www.ncbi.nlm.nih.gov/pubmed/31815004
http://dx.doi.org/10.1038/s41420-019-0232-0
_version_ 1783476506752712704
author Ardestani, Amin
Tremblay, Matthew S.
Shen, Weijun
Maedler, Kathrin
author_facet Ardestani, Amin
Tremblay, Matthew S.
Shen, Weijun
Maedler, Kathrin
author_sort Ardestani, Amin
collection PubMed
description
format Online
Article
Text
id pubmed-6895035
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-68950352019-12-06 Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes Ardestani, Amin Tremblay, Matthew S. Shen, Weijun Maedler, Kathrin Cell Death Discov Comment Nature Publishing Group UK 2019-12-05 /pmc/articles/PMC6895035/ /pubmed/31815004 http://dx.doi.org/10.1038/s41420-019-0232-0 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Comment
Ardestani, Amin
Tremblay, Matthew S.
Shen, Weijun
Maedler, Kathrin
Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes
title Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes
title_full Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes
title_fullStr Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes
title_full_unstemmed Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes
title_short Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes
title_sort neratinib is an mst1 inhibitor and restores pancreatic β-cells in diabetes
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895035/
https://www.ncbi.nlm.nih.gov/pubmed/31815004
http://dx.doi.org/10.1038/s41420-019-0232-0
work_keys_str_mv AT ardestaniamin neratinibisanmst1inhibitorandrestorespancreaticbcellsindiabetes
AT tremblaymatthews neratinibisanmst1inhibitorandrestorespancreaticbcellsindiabetes
AT shenweijun neratinibisanmst1inhibitorandrestorespancreaticbcellsindiabetes
AT maedlerkathrin neratinibisanmst1inhibitorandrestorespancreaticbcellsindiabetes